Trial Profile
Induction vemurafenib followed by consolidative radiation therapy for surgically incurable melanoma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Feb 2016
Price :
$35
*
At a glance
- Drugs Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
- 24 Feb 2016 New trial record